• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Outcomes of Patients With Severe Chronic Lung Disease Who Are Undergoing Transcatheter Aortic Valve Replacement.

作者信息

Suri Rakesh M, Gulack Brian C, Brennan J Matthew, Thourani Vinod H, Dai Dadi, Zajarias Alan, Greason Kevin L, Vassileva Christina M, Mathew Verghese, Nkomo Vuyisile T, Mack Michael J, Rihal Charanjit S, Svensson Lars G, Nishimura Rick A, O'Gara Patrick T, Holmes David R

机构信息

Cleveland Clinic, Cleveland, Ohio.

Duke University, Durham, North Carolina.

出版信息

Ann Thorac Surg. 2015 Dec;100(6):2136-45; discussion 2145-6. doi: 10.1016/j.athoracsur.2015.05.075. Epub 2015 Aug 29.

DOI:10.1016/j.athoracsur.2015.05.075
PMID:26330010
Abstract

BACKGROUND

In this study, we sought to determine the clinical outcomes after transcatheter aortic valve replacement (TAVR) among patients with chronic lung disease (CLD) and to evaluate the safety of transaortic versus transapical alternate access approaches in patients with varying severities of CLD.

METHODS

Clinical records for patients undergoing TAVR from 2011 to 2014 in The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry were linked to Medicare hospital claims (n = 11,656). Clinical outcomes were evaluated across strata of CLD severity, and the risk-adjusted association between access route and post-TAVR mortality was determined among patients with severe CLD.

RESULTS

In this cohort (median age, 84 years; 51.7% female), moderate to severe CLD was present in 27.7% (14.3%, moderate; 13.4%, severe). Compared with patients with no or mild CLD, patients with severe CLD had a higher rate of post-TAVR mortality to 1-year (32.3% versus 21.0%; adjusted hazard ratio [HR], 1.48; 95% confidence interval [CI], 1.31 to 1.66), as did those with moderate CLD (25.5%; adjusted HR, 1.16; 95% CI, 1.03 to 1.30). The adjusted rate of mortality was similar for transapical versus transaortic approaches to 1 year (adjusted HR, 1.17; 95% CI, 0.83 to 1.65).

CONCLUSIONS

Moderate or severe CLD is associated with an increased risk of death to 1-year after TAVR, and among patients with severe CLD, the risk of death appears to be similar with either transapical or transaortic alternate-access approaches. Further study is necessary to understand strategies to mitigate risk associated with CLD and the long-term implications of these findings.

摘要

相似文献

1
Outcomes of Patients With Severe Chronic Lung Disease Who Are Undergoing Transcatheter Aortic Valve Replacement.
Ann Thorac Surg. 2015 Dec;100(6):2136-45; discussion 2145-6. doi: 10.1016/j.athoracsur.2015.05.075. Epub 2015 Aug 29.
2
Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve).慢性肺部疾病合并重度主动脉瓣狭窄患者行经导管主动脉瓣置换术与外科主动脉瓣置换术或标准治疗的结局:PARTNER 试验(经导管主动脉瓣植入术)的观察结果。
J Am Coll Cardiol. 2014 Jan 28;63(3):269-79. doi: 10.1016/j.jacc.2013.09.024. Epub 2013 Oct 16.
3
Transapical and Transaortic Transcatheter Aortic Valve Replacement in the United States.美国经心尖和经主动脉经导管主动脉瓣置换术
Ann Thorac Surg. 2015 Nov;100(5):1718-26; discussion 1726-7. doi: 10.1016/j.athoracsur.2015.05.010. Epub 2015 Jul 29.
4
Long-Term Health Benefit of Transcatheter Aortic Valve Replacement in Patients With Chronic Lung Disease.慢性肺部疾病患者行经导管主动脉瓣置换术的长期健康获益。
JACC Cardiovasc Interv. 2017 Nov 27;10(22):2283-2293. doi: 10.1016/j.jcin.2017.07.025. Epub 2017 Nov 1.
5
Prevalence and Outcomes of Mitral Stenosis in Patients Undergoing Transcatheter Aortic Valve Replacement: Findings From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry.经导管主动脉瓣置换术患者二尖瓣狭窄的患病率和结局:来自胸外科医师学会/美国心脏病学会经导管瓣膜治疗登记处的研究结果。
JACC Cardiovasc Interv. 2018 Apr 9;11(7):693-702. doi: 10.1016/j.jcin.2018.01.245.
6
Association of Tricuspid Regurgitation With Transcatheter Aortic Valve Replacement Outcomes: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.三尖瓣反流与经导管主动脉瓣置换术结果的相关性:来自胸外科医生学会/美国心脏病学会经导管瓣膜治疗登记处的报告。
Ann Thorac Surg. 2018 Apr;105(4):1121-1128. doi: 10.1016/j.athoracsur.2017.11.018. Epub 2018 Mar 2.
7
Stroke and Cardiovascular Outcomes in Patients With Carotid Disease Undergoing Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术治疗颈动脉疾病患者的卒中和心血管结局。
Circ Cardiovasc Interv. 2018 Jun;11(6):e006322. doi: 10.1161/CIRCINTERVENTIONS.117.006322.
8
Clinical outcomes at 1 year following transcatheter aortic valve replacement.经导管主动脉瓣置换术 1 年后的临床结果。
JAMA. 2015 Mar 10;313(10):1019-28. doi: 10.1001/jama.2015.1474.
9
Association Between Peripheral Versus Central Access for Alternative Access Transcatheter Aortic Valve Replacement and Mortality and Stroke: A Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.外周与中心入路经导管主动脉瓣置换术用于建立心外膜旁路的比较,与死亡率和卒中有何关联:来自胸外科医师学会/美国心脏病学会经导管瓣膜治疗注册研究的报告。
Circ Cardiovasc Interv. 2022 Sep;15(9):e011756. doi: 10.1161/CIRCINTERVENTIONS.121.011756. Epub 2022 Sep 20.
10
Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve).在重度主动脉瓣狭窄患者行经导管主动脉瓣置换术或外科主动脉瓣置换术后的结局中存在与性别相关的差异:来自 PARTNER 试验(主动脉瓣经导管置换术)的见解。
J Am Coll Cardiol. 2014 Apr 22;63(15):1522-8. doi: 10.1016/j.jacc.2014.01.036. Epub 2014 Feb 19.

引用本文的文献

1
Readmission rates and risk factors for readmission after transcatheter aortic valve replacement in patients with end-stage renal disease.终末期肾病患者经导管主动脉瓣置换术后再入院率及再入院风险因素。
PLoS One. 2022 Oct 20;17(10):e0276394. doi: 10.1371/journal.pone.0276394. eCollection 2022.
2
Transcatheter aortic valve implantation in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的经导管主动脉瓣植入术
Clin Cardiol. 2022 Feb;45(2):149. doi: 10.1002/clc.23756.
3
Fibrotic Lung Disease at CT Predicts Adverse Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.
CT显示的肺纤维化疾病可预测经导管主动脉瓣置换术患者的不良预后。
Radiol Cardiothorac Imaging. 2020 Apr 30;2(2):e190093. doi: 10.1148/ryct.2020190093. eCollection 2020 Apr.
4
Transcatheter aortic valve implantation in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的经导管主动脉瓣植入术
Clin Cardiol. 2021 Nov;44(11):1487. doi: 10.1002/clc.23523. Epub 2020 Dec 1.
5
Comparison of in-hospital outcomes between octogenarians and nonagenarians undergoing transcatheter aortic valve replacement: a propensity matched analysis.行经导管主动脉瓣置换术的八旬老人与九旬老人的院内结局比较:一项倾向匹配分析。
J Geriatr Cardiol. 2018 Feb;15(2):123-130. doi: 10.11909/j.issn.1671-5411.2018.02.001.
6
Access Options for Transcatheter Aortic Valve Replacement in Patients with Unfavorable Aortoiliofemoral Anatomy.主动脉髂股解剖结构不佳患者经导管主动脉瓣置换术的入路选择
Curr Cardiol Rep. 2016 Nov;18(11):110. doi: 10.1007/s11886-016-0788-8.